## **Core Concept**
The process of gamma-carboxylation of glutamic acid residues in certain proteins, such as clotting factors II (prothrombin), VII, and protein C, is crucial for their biological activity. This post-translational modification allows these proteins to bind calcium ions, which is necessary for their proper functioning in blood coagulation and in the regulation of coagulation pathways.

## **Why the Correct Answer is Right**
The correct answer, Vitamin K, is essential for the gamma-carboxylation process. Vitamin K acts as a cofactor for the enzyme gamma-glutamyl carboxylase, which catalyzes the carboxylation of glutamic acid residues to form gamma-carboxyglutamic acid (Gla). This modification is critical for the calcium-binding properties of these proteins. Without Vitamin K, or in its absence, these clotting factors cannot be properly modified and thus remain inactive.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not specify a known factor involved in the gamma-carboxylation process of glutamic acid residues in clotting factors.
- **Option B:** This option is incorrect as it does not accurately represent a substance known to facilitate gamma-carboxylation of glutamic acid in the context provided.
- **Option D:** This option is incorrect because it does not correspond with the accurate biochemical requirement for gamma-carboxylation.

## **Clinical Pearl / High-Yield Fact**
A critical clinical pearl is that Vitamin K deficiency, or the use of Vitamin K antagonists (such as warfarin), can lead to decreased production of active clotting factors II, VII, IX, and X, and proteins C and S, which can result in bleeding complications. Recognizing this relationship is crucial for managing patients on anticoagulant therapy and for diagnosing and treating coagulopathy.

## **Correct Answer:** .